Bibliographic details
O'Meara S, Nanda KS, Moss AC. Antibodies to infliximab and risk of infusion reactions in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflammatory Bowel Diseases 2014; 20(1): 1-6
MeSH
Anti-Inflammatory Agents, Non-Steroidal /adverse effects; Antibodies, Anti-Idiotypic /blood; Antibodies, Monoclonal /adverse effects; Clinical Trials as Topic; Drug Hypersensitivity /immunology; Humans; Inflammatory Bowel Diseases /blood /drug therapy; Infliximab; Infusions, Intravenous; Meta-Analysis as Topic; Prognosis; Risk Factors